GlassScriptPhysician profile
Jeffrey B Persons
NPI 1265454417
$976.84
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $274 · 2020: $94.73 · 2021: $218 · 2022: $29.67 · 2023: $61.85 · 2024: $299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $361.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $360.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $325.63 | 2019-2024 | Na, Tfn-Advance |
| Stryker Corporation | $147.18 | 2021-2024 | Triathlon |
| Medical Device Business Services, INC. | $123.10 | 2019 | |
| Abbvie INC. | $95.40 | 2024 | |
| Sanofi-Aventis U.S. LLC | $94.73 | 2020 | |
| Lilly USA, LLC | $89.94 | 2024 | Zepbound |
| Pacira Therapeutics, INC. | $37.80 | 2021 | |
| Davol INC. | $27.60 | 2021 | |
| Smith+Nephew, INC. | $22.09 | 2019 | |
| Bioventus LLC | $13.37 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Persons listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.